251 related articles for article (PubMed ID: 20423349)
21. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway.
Yuan YM; Fang SH; Qian XD; Liu LY; Xu LH; Shi WZ; Zhang LH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Sci; 2009 Feb; 109(2):285-92. PubMed ID: 19234368
[TBL] [Abstract][Full Text] [Related]
22. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
23. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
24. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
Cai BL; Huang XQ; Dong XW; Fang SH; Lu YB; Zhang WP; Hu YZ; Shen JG; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):598-604. PubMed ID: 20014485
[TBL] [Abstract][Full Text] [Related]
25. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
Ishimura M; Suda M; Morizumi K; Kataoka S; Maeda T; Kurokawa S; Hiyama Y
Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
[TBL] [Abstract][Full Text] [Related]
26. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4.
Ito Y; Hirano M; Umemoto N; Zang L; Wang Z; Oka T; Shimada Y; Nishimura Y; Kurokawa I; Mizutani H; Tanaka T
BMB Rep; 2008 Feb; 41(2):139-45. PubMed ID: 18315950
[TBL] [Abstract][Full Text] [Related]
27. Cysteinyl Leukotriene Receptor 2 is Involved in Inflammation and Neuronal Damage by Mediating Microglia M1/M2 Polarization through NF-κB Pathway.
Zhao R; Ying M; Gu S; Yin W; Li Y; Yuan H; Fang S; Li M
Neuroscience; 2019 Dec; 422():99-118. PubMed ID: 31726033
[TBL] [Abstract][Full Text] [Related]
28. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
Maekawa A; Kanaoka Y; Lam BK; Austen KF
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
[TBL] [Abstract][Full Text] [Related]
29. Cysteinyl leukotriene receptor assays.
Muccitelli RM; Luttmann MA; Hay DW
Curr Protoc Pharmacol; 2001 May; Chapter 4():Unit 4.16. PubMed ID: 22293965
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid.
Itadani S; Takahashi S; Ima M; Sekiguchi T; Aratani Y; Egashira H; Matsumura N; Inoue A; Yonetomi Y; Fujita M; Nakayama Y; Takeuchi J
Bioorg Med Chem; 2015 May; 23(9):2079-97. PubMed ID: 25800431
[TBL] [Abstract][Full Text] [Related]
31. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
Dupré DJ; Le Gouill C; Gingras D; Rola-Pleszczynski M; Stanková J
J Pharmacol Exp Ther; 2004 Apr; 309(1):102-8. PubMed ID: 14718577
[TBL] [Abstract][Full Text] [Related]
32. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
33. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.
Austen KF; Maekawa A; Kanaoka Y; Boyce JA
J Allergy Clin Immunol; 2009 Sep; 124(3):406-14; quiz 415-6. PubMed ID: 19647860
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
[TBL] [Abstract][Full Text] [Related]
35. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
37. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
38. Expression of functional cysteinyl leukotriene receptors by human basophils.
Gauvreau GM; Plitt JR; Baatjes A; MacGlashan DW
J Allergy Clin Immunol; 2005 Jul; 116(1):80-7. PubMed ID: 15990778
[TBL] [Abstract][Full Text] [Related]
39. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
40. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
